News Articles Tagged: Brain Metastasis

AZD3759: A Breakthrough in Targeted Oncology for Lung Cancer Brain Metastases

Discover AZD3759, a potent EGFR TKI offering enhanced CNS penetration for EGFR-mutant NSCLC with brain metastases, marking a significant advance in targeted therapy.

The Role of AZD3759 in Advancing Brain Metastasis Treatment for NSCLC

Explore AZD3759's role in treating NSCLC brain metastases, highlighting its superior CNS penetration and efficacy as a potent EGFR TKI.

Unlocking the Potential: AZD3759's Impact on EGFR-Mutant NSCLC with Brain Metastases

Explore how AZD3759, a novel CNS-penetrant EGFR TKI, is revolutionizing the treatment landscape for EGFR-mutant NSCLC patients facing brain metastases. Learn about its efficacy and potential.